Efficacy of acupuncture as an adjunctive treatment to patients with stable COPD: a multicenter, randomized, sham-controlled trial protocol.

Authors:
Huang L; Yang S; Xu G; Luo Q; Yang C and 27 more

Journal:
BMC Complement Med Ther

Publication Year: 2024

DOI:
10.1186/s12906-024-04412-6

PMCID:
PMC10918953

PMID:
38454410

Journal Information

Journal Title: BMC Complement Med Ther

Detailed journal information not available.

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis trial will be conducted under the requirements of the Declaration of Helsinki. The entire project has been approved by the Ethics Committee of the Hospital of Chengdu University of Traditional Chinese Medicine (ID: 2022KL-021) and registered in the Chinese Clinical Trials Registry (No. ChiCTR2200058757). Before randomization, patients are required to sign an informed consent form. Subjects' personal information is confidential, and participation in the study is entirely voluntary, with the right to withdraw at any time during any study phase. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was supported by the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine supported this study. (No: ZYYCXTD-D-202003). The funding agency was not involved in the study design, data collection, data analysis, data interpretation, report writing, or submission of the report as an article for publication."

Evidence found in paper:

"Trial registration This study was registered in the Chinese Clinical Trial Registry (ChiCTR2200058757), on April 16, 2022."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025